Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

Cited In for PubMed (Select 15607961)

1.

UVB Stimulates the Expression of Endothelin B Receptor in Human Melanocytes via a Sequential Activation of the p38/MSK1/CREB/MITF Pathway Which Can Be Interrupted by a French Maritime Pine Bark Extract through a Direct Inactivation of MSK1.

Tagashira H, Miyamoto A, Kitamura S, Tsubata M, Yamaguchi K, Takagaki K, Imokawa G.

PLoS One. 2015 Jun 1;10(6):e0128678. doi: 10.1371/journal.pone.0128678. eCollection 2015.

2.

NUAK2 Amplification Coupled with PTEN Deficiency Promotes Melanoma Development via CDK Activation.

Namiki T, Yaguchi T, Nakamura K, Valencia JC, Coelho SG, Yin L, Kawaguchi M, Vieira WD, Kaneko Y, Tanemura A, Katayama I, Yokozeki H, Kawakami Y, Hearing VJ.

Cancer Res. 2015 Jul 1;75(13):2708-15. doi: 10.1158/0008-5472.CAN-13-3209. Epub 2015 Apr 1.

PMID:
25832654
3.

A novel role for microphthalmia-associated transcription factor-regulated pigment epithelium-derived factor during melanoma progression.

Dadras SS, Lin RJ, Razavi G, Kawakami A, Du J, Feige E, Milner DA, Loda MF, Granter SR, Detmar M, Widlund HR, Horstmann MA, Fisher DE.

Am J Pathol. 2015 Jan;185(1):252-65. doi: 10.1016/j.ajpath.2014.09.012. Epub 2014 Nov 6.

PMID:
25447045
4.

MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor (MITF) mRNA is inhibited by coding region determinant-binding protein (CRD-BP).

Goswami S, Tarapore RS, Poenitzsch Strong AM, TeSlaa JJ, Grinblat Y, Setaluri V, Spiegelman VS.

J Biol Chem. 2015 Jan 2;290(1):384-95. doi: 10.1074/jbc.M114.590158. Epub 2014 Nov 20.

PMID:
25414259
5.

Inferring protein modulation from gene expression data using conditional mutual information.

Giorgi FM, Lopez G, Woo JH, Bisikirska B, Califano A, Bansal M.

PLoS One. 2014 Oct 14;9(10):e109569. doi: 10.1371/journal.pone.0109569. eCollection 2014.

6.

The roles of microphthalmia-associated transcription factor and pigmentation in melanoma.

Hsiao JJ, Fisher DE.

Arch Biochem Biophys. 2014 Dec 1;563:28-34. doi: 10.1016/j.abb.2014.07.019. Epub 2014 Aug 9. Review.

PMID:
25111671
7.

Drug design of cyclin-dependent kinase 2 inhibitor for melanoma from traditional Chinese medicine.

Tang HC, Chen CY.

Biomed Res Int. 2014;2014:798742. doi: 10.1155/2014/798742. Epub 2014 Jun 19.

8.

Loss of MITF expression during human embryonic stem cell differentiation disrupts retinal pigment epithelium development and optic vesicle cell proliferation.

Capowski EE, Simonett JM, Clark EM, Wright LS, Howden SE, Wallace KA, Petelinsek AM, Pinilla I, Phillips MJ, Meyer JS, Schneider BL, Thomson JA, Gamm DM.

Hum Mol Genet. 2014 Dec 1;23(23):6332-44. doi: 10.1093/hmg/ddu351. Epub 2014 Jul 9.

PMID:
25008112
9.

SWI/SNF chromatin remodeling enzymes in melanocyte differentiation and melanoma.

Mehrotra A, Mehta G, Aras S, Trivedi A, de la Serna IL.

Crit Rev Eukaryot Gene Expr. 2014;24(2):151-61. Review.

10.

Tumor suppressor DYRK1A effects on proliferation and chemoresistance of AML cells by downregulating c-Myc.

Liu Q, Liu N, Zang S, Liu H, Wang P, Ji C, Sun X.

PLoS One. 2014 Jun 5;9(6):e98853. doi: 10.1371/journal.pone.0098853. eCollection 2014.

11.

Pathways and therapeutic targets in melanoma.

Shtivelman E, Davies MQ, Hwu P, Yang J, Lotem M, Oren M, Flaherty KT, Fisher DE.

Oncotarget. 2014 Apr 15;5(7):1701-52. Review.

12.

SIRT1 promotes proliferation and inhibits the senescence-like phenotype in human melanoma cells.

Ohanna M, Bonet C, Bille K, Allegra M, Davidson I, Bahadoran P, Lacour JP, Ballotti R, Bertolotto C.

Oncotarget. 2014 Apr 30;5(8):2085-95.

13.

The GIST of targeted therapy for malignant melanoma.

Bello DM, Dematteo RP, Ariyan CE.

Ann Surg Oncol. 2014 Jun;21(6):2059-67. doi: 10.1245/s10434-013-3373-z. Epub 2014 Feb 15. Review.

14.

Novel roles for the MiTF/TFE family of transcription factors in organelle biogenesis, nutrient sensing, and energy homeostasis.

Martina JA, Diab HI, Li H, Puertollano R.

Cell Mol Life Sci. 2014 Jul;71(13):2483-97. doi: 10.1007/s00018-014-1565-8. Epub 2014 Jan 30. Review.

15.

Melanoma: from melanocyte to genetic alterations and clinical options.

Bertolotto C.

Scientifica (Cairo). 2013;2013:635203. doi: 10.1155/2013/635203. Epub 2013 Dec 12. Review.

16.

Acid sphingomyelinase determines melanoma progression and metastatic behaviour via the microphtalmia-associated transcription factor signalling pathway.

Bizzozero L, Cazzato D, Cervia D, Assi E, Simbari F, Pagni F, De Palma C, Monno A, Verdelli C, Querini PR, Russo V, Clementi E, Perrotta C.

Cell Death Differ. 2014 Apr;21(4):507-20. doi: 10.1038/cdd.2013.173. Epub 2013 Dec 6.

17.

SOX10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesis.

Cronin JC, Watkins-Chow DE, Incao A, Hasskamp JH, Sch├Ânewolf N, Aoude LG, Hayward NK, Bastian BC, Dummer R, Loftus SK, Pavan WJ.

Cancer Res. 2013 Sep 15;73(18):5709-18. doi: 10.1158/0008-5472.CAN-12-4620. Epub 2013 Aug 1.

18.

Microphthalmia transcription factor regulates pancreatic ╬▓-cell function.

Mazur MA, Winkler M, Ganic E, Colberg JK, Johansson JK, Bennet H, Fex M, Nuber UA, Artner I.

Diabetes. 2013 Aug;62(8):2834-42. doi: 10.2337/db12-1464. Epub 2013 Apr 22.

19.

Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB.

Tripathi V, Shen Z, Chakraborty A, Giri S, Freier SM, Wu X, Zhang Y, Gorospe M, Prasanth SG, Lal A, Prasanth KV.

PLoS Genet. 2013 Mar;9(3):e1003368. doi: 10.1371/journal.pgen.1003368. Epub 2013 Mar 21.

20.

Vax1/2 genes counteract Mitf-induced respecification of the retinal pigment epithelium.

Ou J, Bharti K, Nodari A, Bertuzzi S, Arnheiter H.

PLoS One. 2013;8(3):e59247. doi: 10.1371/journal.pone.0059247. Epub 2013 Mar 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk